By Matthew Guarnaccia ( July 30, 2019, 8:09 PM EDT) -- Investors for Swedish cancer biotechnology firm Oasmia launched a proposed class action lawsuit in New York federal court Monday, alleging the company actively concealed a number of deals involving entities owned by the biotech's founder and a former board member....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.